Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Louis P. Garrison, Jr"'
Autor:
Philip O. Buck, Dumingu Aparna Gomes, Ekkehard Beck, Noam Kirson, Matthew Mattera, Stuart Carroll, Bernhard Ultsch, Kavisha Jayasundara, Mathieu Uhart, Louis P. Garrison, Jr.
Publikováno v:
Vaccines, Vol 12, Iss 3, p 234 (2024)
The COVID-19 pandemic’s dramatic impact has been a vivid reminder that vaccines—especially in the context of infectious respiratory viruses—provide enormous societal value, well beyond the healthcare system perspective which anchors most Health
Externí odkaz:
https://doaj.org/article/7952172987994499adfb351a5b30b4ed
Autor:
Horacio A. Duarte, Joseph B. Babigumira, Eva A. Enns, David C. Stauffer, Robert W. Shafer, Ingrid A. Beck, Louis P. Garrison, Jr., Michael H. Chung, Lisa M. Frenkel, Eran Bendavid
Publikováno v:
EClinicalMedicine, Vol 22, Iss , Pp - (2020)
Background: The prevalence of pre-treatment drug resistance (PDR) to non-nucleoside reverse-transcriptase inhibitor (NNRTI) agents is increasing in sub-Saharan Africa, which may decrease the effectiveness of efavirenz-based antiretroviral therapy (AR
Externí odkaz:
https://doaj.org/article/48048c2982b14063b4e04fa06aa94da6
Autor:
Meng Li, Agnes Nyabigambo, Patricia Navvuga, Elly Nuwamanya, Afra Nuwasiima, Paschal Kaganda, Francis T. Asiimwe, Elisabeth Vodicka, Noleb M. Mugisha, Aggrey Mukose, Doris K. Kwesiga, Solomon J. Lubinga, Louis P. Garrison, Jr, Joseph B. Babigumira
Publikováno v:
Papillomavirus Research, Vol 4, Iss , Pp 17-21 (2017)
Objective: To evaluate the acceptability and performance of cervical cancer (CC) screening using visual inspection with acetic acid (VIA) integrated into a rural immunization clinic in Uganda. Methods/materials: We conducted a cross-sectional pilot s
Externí odkaz:
https://doaj.org/article/1dbd0e79195f46e090a72ce2001e67f1
Autor:
Malaz Boustani, Erin G. Doty, Louis P. Garrison Jr, Lee J. Smolen, Timothy M. Klein, Daniel R. Murphy, Andrew W. Spargo, Mark Belger, Joseph A. Johnston
Publikováno v:
Neurology and Therapy, Vol 13, Iss 6, Pp 1641-1659 (2024)
Abstract Introduction The goal of this economic model is to estimate an economically justifiable price (EJP) for using donanemab for the treatment of early symptomatic Alzheimer’s disease (AD) in the United States based on clinical data from the ph
Externí odkaz:
https://doaj.org/article/354ca1848d6343b1a1e13ff64ed0b068
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 10 (2024)
Externí odkaz:
https://doaj.org/article/0e443eabfc8c467aa15cfb0a3f5ac51b
Autor:
Sreeram V Ramagopalan, Manuel Gomes, Isabelle Durand-Zaleski, Bill Malcolm, Jose Diaz, Grace Mitchell, Jonathan Pearson-Stuttard, Louis P Garrison Jr
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/f24885864e734f09994c94a4839754e2